BNY Mellon Concentrated Growth ETF

BNY Mellon Concentrated Growth ETF (BKCG) is an actively managed fund. Its sub-adviser, Fayez Sarofim & Co., picks 25 to 35 large growth companies and holds them for the long term. Its 0.50% expense ratio is higher than all seven similar growth ETFs it was compared with, which average 0.09%. Its portfolio pairs tech giants like NVIDIA with less typical growth names such as Philip Morris and BAE Systems.

• The deepest fall in its price history was 4.2% (Jun 15, 2026 to Jun 25, 2026), recovered by Jul 6, 2026.

No distribution history is available for this fund.

As of Jul 31, 2026, the fund held 28 securities; the ten largest made up 56.04% of assets, and 3.18% sat in cash and money-market holdings.

By sector

• Over the three months to Jul 31, 2026, investors withdrew a net $2.2M (creations minus redemptions, per the N-PORT report).
• Monthly total returns reported for that quarter: +3.02%, -2.79%, +3.00%.

BKCG does not track an index. Its sub-adviser, Fayez Sarofim & Co., chooses every stock. The fund normally keeps at least 80% of net assets in "growth" companies. The prospectus defines these as businesses whose revenue the sub-adviser expects to grow faster than the US economy, and whose earnings or cash flow per share could keep rising. Each company must be worth $5 billion or more when the fund buys it.

Sarofim starts with sectors it expects to grow over the next three to five years or longer. Within those sectors, it uses fundamental analysis (studying each company's business and finances). It looks for firms with dominant industry positions, steady profits, strong balance sheets or growing global reach, ideally at an undervalued price. The fund typically holds 25 to 35 companies. As of July 31, 2026, it held 28, and the top 10 made up 56% of assets. The prospectus gives no fixed weighting formula or rebalancing schedule. Sarofim buys and holds, and portfolio turnover was 14.05%. It usually sells only when a company's business seems to have weakened for good.

The fund is non-diversified, so it can put large amounts into a few companies. It may invest up to 10% of net assets directly in foreign stocks. It can also buy American Depositary Receipts (ADRs), which are US-traded shares of foreign companies such as Taiwan Semiconductor and BAE Systems. It held no derivatives as of July 31, 2026.

• BKCG charges 0.5% a year, versus an average of 0.09% for the similar funds below (8th of 8, cheapest first).
• Using the prospectus's standard example, $10,000 invested would cost about $51 in the first year and $628 over 10 years (assuming a 5% annual return).

It is a non-diversified, actively managed portfolio of about 28 growth stocks that charges far more than broad growth index funds.

BKCG could add a hand-picked group of large growth stocks next to a broader core holding. Its own trading record is short. Price data starts June 9, 2026, and its deepest drop since then was 4.2%. That drop ran from June 15 to June 25, 2026, and was recovered by July 6. The prospectus record goes back to 2016, before the ETF launched on March 31, 2025. It shows an 18.22% loss in 2022, the worst calendar year from 2016 through 2025, and a 16.08% fall in early 2020. It doesn't cover 2008. Anyone who may need to sell shares in a bad year should expect drops of that size. Income is small: the yield was 0.25% as of October 27, 2026, paid quarterly. In the SEC's standard example, $10,000 would cost $628 in fees over 10 years. Past results don't predict future ones, and a plan should look at the whole portfolio, not one fund.

Matched by holdings overlap from the latest N-PORT reports.